Caption Management, LLC Fibrogen Inc Put Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $293,322 - $2.43 Million	117,800 Added 273.95%	160,800 $434,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $685,850 - $1.08 Million	43,000 New	43,000 $802,000
Q4 2021 Feb 11, 2022	BUY	$9.93 - $15.39 $64,545 - $100,035	6,500 Added 8.84%	80,000 $1.13 Million
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $2.28 Million - $5.95 Million	-223,500 Reduced 75.25%	73,500 $751,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $5.24 Million - $10.1 Million	282,000 Added 1880.0%	297,000 $7.91 Million
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $1.94 Million - $3.06 Million	-55,100 Reduced 78.6%	15,000 $678,000
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $3 Million - $4.2 Million	70,100 New	70,100 $3.81 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.